Inhaled Fasudil Lacks Pulmonary Selectivity in Thromboxane-Induced Acute Pulmonary Hypertension in Newborn Lambs

Journal of Cardiovascular Pharmacology and Therapeutics
Shawn F L HansonParesh C Giri

Abstract

Pulmonary hypertension (PH) is a potentially deadly disease for infants and adults with few existing medical interventions and no cure. In PH, increased blood pressure in the pulmonary artery eventually leads to heart failure. Fasudil, an antagonist of Rho-kinase, causes vasodilation leading to decreased systemic artery pressure and pulmonary artery pressure (PAP). This study compared the effects of fasudil administered as either an intravenous infusion or inhaled aerosol in newborn lambs. Inhaled aerosol delivery of fasudil will provide selective pulmonary vasodilation when compared with intravenous administration. Newborn lambs (∼11 days) were surgically instrumented and mechanically ventilated under anesthesia. A pulmonary artery catheter and ultrasonic flow probe were inserted to measure hemodynamics. Acute PH was pharmaceutically induced via continuous intravenous infusion of thromboxane. After achieving a 2- to 3-fold elevation of PAP, fasudil was administered either as intravenous infusion (2.5 mg/kg) or inhaled aerosol (100 mg of fasudil in 2 mL of saline). Changes in PAP, mean systemic arterial pressure (MABP), pulmonary vascular resistance (PVR), systemic vascular resistance (SVR), cardiac output, and heart rate were ...Continue Reading

References

Oct 26, 2001·Japanese Journal of Pharmacology·S SatoH Shimokawa
Jan 16, 2002·International Journal of Pharmaceutics·Tatsuhiro IshidaHiroshi Kiwada
Apr 1, 2003·The Journal of Physiology·Christian J HunterGordon G Power
Jun 10, 2003·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Sandra S GarnerDavid J Annibale
Feb 24, 2004·American Journal of Physiology. Lung Cellular and Molecular Physiology·Karen A FaganIvan F McMurtry
Sep 14, 2004·Nature Medicine·Christian J HunterMark T Gladwin
Nov 26, 2004·American Journal of Respiratory and Critical Care Medicine·Tetsutaro NagaokaMasahiko Oka
May 14, 2005·Expert Review of Cardiovascular Therapy·Yoshiyuki Rikitake, James K Liao
Dec 3, 2005·Journal of Applied Physiology·Tetsutaro NagaokaMasahiko Oka
Nov 23, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Patrick J McNamaraRobert P Jankov
Jun 10, 2008·British Journal of Pharmacology·M OkaI F McMurtry
Aug 12, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Adeleke M BadejoPhilip J Kadowitz
Jul 11, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Zhulanqiqige Do eHiroaki Shimokawa
Mar 6, 2010·Advances in Experimental Medicine and Biology·Ivan F McMurtryMasahiko Oka
Dec 22, 2011·Journal of Pharmacological Sciences·Shin-ichi SatohToshio Asano
Nov 16, 2012·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Arlin B BloodSean M Wilson
Jan 29, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Vivek GuptaFakhrul Ahsan
Aug 6, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Yoshihiro FukumotoHiroaki Shimokawa
Aug 8, 2013·Journal of Cardiovascular Pharmacology·Jianjian Shi, Lei Wei
Dec 21, 2013·Journal of the American College of Cardiology·D Dunbar IvyMaurice Beghetti
Dec 21, 2013·Journal of the American College of Cardiology·Gerald SimonneauRogiero Souza
Dec 21, 2013·Journal of the American College of Cardiology·Rubin M TuderNicholas W Morrell
Dec 21, 2013·Journal of the American College of Cardiology·Mardi Gomberg-MaitlandLewis J Rubin
Apr 5, 2014·Chest·Mary G GeorgeShaleah Levant
Feb 7, 2017·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Zhengsheng MaoXin Di
Jan 1, 2012·Journal of Pharmacological Sciences·Shin-Ichi SatohToshio Asano

❮ Previous
Next ❯

Citations

Apr 30, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Taslim A Al-HilalFakhrul Ahsan

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase

Software Mentioned

Prism
GraphPad
Excel
Power
LabChart

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.